Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
The Journal of Biological Chemistry|May 30, 2002
A spindle checkpoint arrest and a cytokinesis failure by the dominant-negative polo-box domain of Plk1 in U-2 OS cellsYeon-Sun Seong, Keiju Kamijo, Jae-Seon Lee, et al.Biochemical and Biophysical Research Communications|August 1, 2006
A cytoskeleton-associated protein, TMAP/CKAP2, is involved in the proliferation of human foreskin fibroblastsSang-Min Jeon, Bongkun Choi, Kyung Uk Hong, et al.BMB Reports|August 7, 2008
BMI-1026 treatment can induce SAHF formation by activation of Erk1/2Hyun-Joo Seo, Hye Jeong Park, Hyung Su Choi, et al.Experimental & Molecular Medicine|December 28, 2007
The centrosomal localization of KM-HN-1 (MGC33607) depends on the leucine zipper motif and the C-terminal coiled-coil domainHye Jeong Park, Hyun-Joo Seo, Hyun-Woo Kim, et al.Cell Cycle (Georgetown, Tex.)|May 5, 2009
Depletion of BubR1 promotes premature centrosomal localization of cyclin B1 and accelerates mitotic entrySun-Yi Park, Sujeong Kim, Hyeseon Cho, et al.Scientific Reports|December 4, 2014
HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interactionHyo Jin Kang, Yong Weon Yi, Young Bin Hong, et al.International Journal of Oncology|March 29, 2014
Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cellsHong-Quan Duong, Yong Weon Yi, Hyo Jin Kang, et al.The Journal of Biological Chemistry|April 17, 2009
Cdk1-cyclin B1-mediated phosphorylation of tumor-associated microtubule-associated protein/cytoskeleton-associated protein 2 in mitosisKyung Uk Hong, Hyun-Jun Kim, Hyo-Sil Kim, et al.Journal of Cellular and Molecular Medicine|April 23, 2013
Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cellsYong Weon Yi, Wooyoung Hong, Hyo Jin Kang, et al.Cancers|November 11, 2022
Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer CellsYong Weon Yi, Kyu Sic You, Sanghee Han, et al.Pageof 5